Abstract:Background Choriocarcinoma is a highly aggressive, malignant trophoblastic neoplasm that can be gestational or non-gestational in origin. Accurate discrimination between these two subtypes, the causative pregnancy type, and the pregnancy-to-treatment interval for gestational choriocarcinoma are vital for clinical management. Methods Fifteen choriocarcinomas were genotyped using multiplex fluorescent polymerase chain reaction amplification of 15 short tandem repeat (STR) loci and the amelogenin locus (XY determination). Genotype patterns at each locus from tumoral and maternal tissues were compared, and any prior or concurrent mole/placenta was also compared when available. According to STR results showing the presence or absence of the paternal chromosomal complement, the gestational or non-gestational origin of the tumor and the nature of the causative pregnancy was identified. Results Fourteen tumors were gestational. Of these, seven were androgenetic/homozygous XX, and two were androgenetic/heterozygous XX, indicating that the causative pregnancies were molar pregnancies. Among the nine molar pregnancies, five were of the occult type. A menopausal patient developed a tumor from a mole that occurred seven years ago, identified by the genetically identical allele from the tumor and prior mole. One tumor originating from a previous mole was interrupted by term delivery. Two tumors found eight weeks postpartum were identified as originating from a prior occult mole. A pelvic choriocarcinoma was separated from a genetically distinct third trimester intrauterine placenta. Five gestational tumors were biparental: 2 XX, 3 XY. Of three ovarian tumors, two were confirmed gestational (1 androgenetic/homozygous XX; 1 biparental XY), and one was an ovarian tumor (XX) with a complete match of the genotype for all 15 loci, therefore ascertaining its non-gestational origin. Conclusion Gestational choriocarcinoma can originate in an androgenetic or biparental manner. The majority are androgenetic/homozygous XX, while a large number of them might be occult molar pregnancies. The origin of ectopic androgenetic choriocarcinoma with concurrent intrauterine placenta might be from either dispermic twin gestation (mole and coexistent nonmolar fetus) or an antecedent molar pregnancy. Choriocarcinoma shortly postpartum might not be associated with the last placenta. STR analysis can be useful in distinguishing gestational choriocarcinoma from non-gestational, as well as the causative pregnancy, and serve as a helpful examination tool for guiding clinical management.

Human Chorionic Gonadotropin (Hcg) Beta-Core Fragment Is Produced By Degradation Of Hcg Or Free Hcg Beta In Gestational Trophoblastic Tumors: A Possible Marker For Early Detection Of Persistent Postmolar Gestational Trophoblastic Disease

HCG-Activated Human Peripheral Blood Mononuclear Cells (PBMC) Promote Trophoblast Cell Invasion

Human chorionic gonadotropin beta-core fragment is directly produced by cancer cells.

[Expression and Significance of LMP2 and PPM1A in Gestational Trophoblastic Disease].

Challenges in Diagnosing Hydatidiform Moles: a Review of Promising Molecular Biomarkers.

A Novel Prediction Model For Postmolar Gestational Trophoblastic Neoplasia And Comparison With Existing Models

[Persistent low levels of human chorionic gonadotropin in the serum: investigation and management]

Differential expression of insulin-like growth factor binding protein 1 and ferritin light polypeptide in gestational trophoblastic neoplasia: combined cDNA suppression subtractive hybridization and microarray study.

Minichromosome maintenance protein 7 expression in gestational trophoblastic disease: correlation with Ki67, PCNA and clinicopathological parameters.

Curious phenomenon of 'hook effect' in invasive mole

Using Short Tandem Repeat Analysis for Choriocarcinoma Diagnosis: a Case Series

Specific detection of type II human chorionic gonadotropin beta subunit produced by trophoblastic and neoplastic cells

Telomerase RNA and Telomerase Activity in Trophoblastic Tumors

Twin Pregnancy with Complete Hydatidiform Mole and Co-Existing Fetus: A Report of 15 Cases with a Clinicopathological Analysis and DNA Genotyping.

[Mismatch Repair Gene Promoter Methylation and Expression in Hydatidiform Moles and the Malignant Transformation].

Telomerase Activity in Gestational Trophoblastic Disease

Determination of human chorionic gonadotropin

Levels of Placenta Growth Factor in Gestational Trophoblastic Diseases.

Serial hCG and ultrasound measurements for predicting malignant potential in multiple pregnancies associated with complete hydatidiform mole: a report of 2 cases

Combination assay of urinary beta-core fragment of human chorionic gonadotropin with serum tumor markers in gynecologic cancers

Human Papillomavirus Type 18 DNA in Gestational Trophoblastic Tissues and Choriocarcinomas